Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1-like 3 pseudogene

Molecular classification
Pseudogene, Non-coding RNA gene (if transcribed, but generally lacking functional product)
01

Overview

Heterogeneous nuclear ribonucleoprotein A1-like 3 pseudogene (ENSG00000229110, LOC100421387) is a nonfunctional DNA segment sharing strong sequence similarity with the functional heterogeneous nuclear ribonucleoprotein A1 gene. Like other pseudogenes, it lacks key regulatory features or contains disabling mutations that prevent expression of a functional protein product[2][3]. Pseudogenes may occasionally be transcribed into non-coding RNAs or play indirect roles in gene regulation, such as acting as microRNA decoys or affecting RNA interference pathways, but these functions are rare and not established for this particular gene[5]. It is not considered a classical drug target and has no known therapeutic relevance. In summary, this entity is best classified as a pseudogene, not a functional receptor, and should not be considered a therapeutic target for drug development or pharmacological intervention[2][3].

Other names
LOC100421387HNRPA1L3 pseudogene
02

Biological functions

Possible regulation of parent gene expression via transcript interference, RNA decoys, or as a source of noncoding RNAsGenerally non-functional; any biological activities would be atypical and highly context-dependent
03

Disease associations

Other (pseudogenes can—in rare cases—contribute to gene regulation or disease, but no specific disease association with this particular pseudogene is documented)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1-like 3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1-like 3 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call